Mandate

Vinge advises Precio Fishbone in connection with the sale of shares in a subsidiary company

Vinge advises Precio Fishbone AB (publ) (”Precio Fishbone”) in connection with the sale of approximately 80.1 per cent of the shares in the subsidiary Precio Fishbone Systems AB ("Omnia"), including the product Omnia Digital Workplace, to Monterro.

Omnia Digital Workplace has been awarded in several different international contexts and has for six consecutive years been ranked as the market's best SaaS product for creating a modern digital workplace.

Monterro acquires a majority stake of approximately 80.1 per cent in Omnia from Precio Fishbone while Precio Fishbone retains a minority stake of approximately 19.9 per cent. Omnia has been created through a restructuring whereby all operations and employees related to the product Omnia Digital Workplace have been transferred from Precio Fishbone to the previously wholly owned subsidiary Omnia. All shares in Omnia are transferred to a company that will be indirectly owned by Monterro and Precio Fishbone. The purchase price for the approximately 80.1 per cent of the shares in Omnia indirectly transferred to Monterro amounts to SEK 168 million. Omnia also owns Omnia Systems Ltd (Vietnam), Precio Fishbone Canada Inc, Precio Fishbone Danmark ApS and has a branch in Germany.

Vinge’s team consisted of Matthias Pannier, Gustav Persson, Maximilian Bengtsson (M&A), Dain Hård Nevonen, William Kåge (Capital Markets), Mathilda Persson (Corporate Commercial), Rebecka Målquist (Intellectual Property) and Fanny Askelöf (Transaction Support Specialist).

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025